Notably, deletion of the insulin receptor in myeloid cells reduces macrophage infiltration during HFD, decreases circulating levels of TNF-α and protects against HFD-induced insulin resistance, highlighting insulin’s potential negative role in innate immune responses during MetS. This evidence concerns the gene INS and metabolic syndrome.